ASND Ascendis Pharma A/S
- 135.900
- -1.030-0.75%
- 135.900
- 0.0000.00%
Ascendis Pharma A/S News
Ascendis Pharma Analyst Ratings
Ascendis Pharma Analyst Ratings
Ascendis Pharma Analyst Ratings
Ascendis Pharma Analyst Ratings
Ascendis Pharma Analyst Ratings
Ascendis Pharma Analyst Ratings
Ascendis Pharma Analyst Ratings
Wedbush Raises Price Target on Ascendis Pharma to $207 From $202, Maintains Outperform Rating
Cantor Fitzgerald Reiterates Overweight on Ascendis Pharma, Maintains $152 Price Target
Jefferies Initiates Coverage On Ascendis Pharma With Buy Rating, Announces Price Target of $150
Ascendis Pharma Analyst Ratings
Wells Fargo Maintains Overweight on Ascendis Pharma, Raises Price Target to $149
Ascendis Pharma Analyst Ratings
Wedbush Adjusts Ascendis Pharma A/S Price Target to $200 From $192, Maintains Outperform Rating
Ascendis Pharma Analyst Ratings
Wedbush Reiterates Outperform on Ascendis Pharma, Maintains $192 Price Target
Ascendis Pharma Analyst Ratings
The Latest Analyst Ratings for Ascendis Pharma
Cantor Fitzgerald Reiterates Overweight on Ascendis Pharma, Maintains $152 Price Target
Ascendis Pharma Analyst Ratings
Analysis
Price Target
No Data
